Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000253691 | SCV000319169 | benign | Cardiovascular phenotype | 2015-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000441585 | SCV000530371 | benign | not specified | 2017-06-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000470015 | SCV000557809 | benign | Primary dilated cardiomyopathy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528755 | SCV004700286 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | TXNRD2: BP4, BS2 |
Diagnostic Laboratory, |
RCV001528755 | SCV001741049 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001528755 | SCV001928850 | likely benign | not provided | no assertion criteria provided | clinical testing |